Organization
Oral and Maxillofacial Surgery, University of Groningen, Groningen
1 abstract
Abstract
ABATACEPT TREATMENT TARGETS TFH-CELLS IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME Org: Rheumatology and Clinical Immunology Section, Oral and Maxillofacial Surgery, University of Groningen, Groningen, Pulmonary Medicine, Erasmus Medical Center, Rotterdam, Netherlands,